idarubicin hydrochloride

Poland

Drugs containing this active substance

  • IDARUBICIN ACCORD

    The medicine is used to treat acute myeloid leukemia (in adults to induce remission and in children as first-line treatment in combination with cytarabine) and acute lymphoblastic leukemia (as a second-line treatment).

    Form: solution for injection

    Active substance Dosage
    idarubicin hydrochloride 5 mg/5 ml

    ATC: L01DB06

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • IDARUBICIN ACCORD

    The medicine is used to treat acute myeloid leukemia and acute lymphoblastic leukemia in adults and children. It may also be used in combination with other anticancer drugs.

    Form: solution for injection

    Active substance Dosage
    idarubicin hydrochloride 10 mg/10 ml

    ATC: L01DB06

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • IDARUBICIN ACCORD

    The medicinal product is used in the treatment of acute myeloid leukaemia (in adults to induce remission, in children as first-line treatment in combination with cytarabine) and acute lymphoblastic leukaemia (in adults as second-line treatment, in children as second-line treatment).

    Form: solution for injection

    Active substance Dosage
    idarubicin hydrochloride 20mg/20ml

    ATC: L01DB06

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • ZAVEDOS

    The medicinal product is used to treat certain blood cancers, such as acute myeloid leukemia and acute lymphoblastic leukemia, in both adults and children.

    Form: powder for preparation of injection solution

    Active substance Dosage
    idarubicin hydrochloride 5 mg

    ATC: L01DB06

    Manufacturer: Actavis Italy S.p.A.

  • ZAVEDOS

    The medicine is used to treat certain blood cancers, such as acute myeloid leukemia and acute lymphoblastic leukemia, in both adults and children.

    Form: powder for preparation of injection solution

    Active substance Dosage
    idarubicin hydrochloride 10 mg

    ATC: L01DB06

    Manufacturer: Actavis Italy S.p.A.

  • ZAVEDOS

    The medicine is used in adults and children for the treatment of various types of acute leukemia (non-lymphoblastic and lymphoblastic).

    Form: solution for injection

    Active substance Dosage
    idarubicin hydrochloride 1 mg/ml

    ATC: L01DB06

    Manufacturer: Pfizer Service Company BV